Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eightNCI to remain intact, but its finances are uncertain; FDA is spared big cuts April 18, 2025Vol.51 No.15By Paul Goldberg
Clinical Roundup Inherited cancer mutations may drive tumor growth, study shows April 18, 2025Vol.51 No.15
Podcast In The Headlines: Private funding can’t replace federal funding—but it can help April 09, 2025Vol.51 No.13
Guest Editorial Rathmell: We must put the individual at the center of our approach to ending cancer April 04, 2025Vol.51 No.13By W. Kimryn Rathmell
FreeIn the Archives In an oral history now taken down by FDA, Andrew von Eschenbach recounts his stint as the head of both FDA and NCI—simultaneously April 04, 2025Vol.51 No.13By Jacquelyn Cobb
Clinical Roundup Fatty acids promote immune suppression and therapy resistance in triple negative breast cancer, Baylor Medicine study finds April 04, 2025Vol.51 No.13
Conversation with The Cancer Letter Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State March 28, 2025Vol.51 No.12By Paul Goldberg
Capitol Hill Kennedy announces massive cuts, centralization at HHS—NCI and FDA hitAlso this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology March 28, 2025Vol.51 No.12By Claire Marie Porter and Jacquelyn Cobb
Clinical Roundup Even light daily physical activity linked to lower cancer risk, NIH and Oxford study shows March 28, 2025Vol.51 No.12
